175 related articles for article (PubMed ID: 26260644)
1. What Does Provider Status Mean for Pharmacists?
Consult Pharm; 2015 Aug; 30(8):478-80. PubMed ID: 26260644
[No Abstract] [Full Text] [Related]
2. Pharmacist provider status legislation: Projections and prospects.
Harper PC
J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
[TBL] [Abstract][Full Text] [Related]
3. Sweeping CMS Proposal Would Acknowledge Role of Pharmacists.
Consult Pharm; 2015 Sep; 30(9):544. PubMed ID: 26350895
[No Abstract] [Full Text] [Related]
4. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
[No Abstract] [Full Text] [Related]
5. Medicare part D: good for patients and an opportunity for pharmacists.
Benner JS; Kocot SL
J Manag Care Pharm; 2009; 15(1):66-70. PubMed ID: 19125552
[No Abstract] [Full Text] [Related]
6. Pharmacist 'provider status' legislation introduced into the Senate.
Young D
Am J Health Syst Pharm; 2003 Aug; 60(15):1502. PubMed ID: 12951746
[No Abstract] [Full Text] [Related]
7. HCFA clarifies 'incident-to' billing by pharmacists.
Am J Health Syst Pharm; 2000 Sep; 57(17):1557-8. PubMed ID: 10984801
[No Abstract] [Full Text] [Related]
8. CMS chief affirms incident-to billing for pharmacists is allowed.
Traynor K
Am J Health Syst Pharm; 2014 Jun; 71(12):977-8. PubMed ID: 24865750
[No Abstract] [Full Text] [Related]
9. Report of the APhA and APhA-ASP Houses of Delegates.
Bzowyckyj A; Oestreich J; Kirk LM
J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
[No Abstract] [Full Text] [Related]
10. New York pharmacists push for CDTM.
Traynor K
Am J Health Syst Pharm; 2013 Nov; 70(21):1870, 1872. PubMed ID: 24128953
[No Abstract] [Full Text] [Related]
11. The Medicare Part D Season Begins, Again.
Baldwin P
Consult Pharm; 2018 Mar; 33(3):172. PubMed ID: 29720303
[No Abstract] [Full Text] [Related]
12. PROGRESS REPORT: Provider Status Continues to Gain Strength!
Menighan TE
Int J Pharm Compd; 2015; 19(5):437. PubMed ID: 26775452
[No Abstract] [Full Text] [Related]
13. Econometric studies on pharmacist care services are lacking--a call for papers.
Soller RW
Int J Pharm Pract; 2012 Apr; 20(2):69-70. PubMed ID: 22416930
[No Abstract] [Full Text] [Related]
14. Health care reform law offers opportunities for pharmacists.
Batshon L
Consult Pharm; 2010 Jun; 25(6):388. PubMed ID: 20534410
[No Abstract] [Full Text] [Related]
15. How did we get here from there?
Schuh MJ
J Am Pharm Assoc (2003); 2008; 48(4):442-4. PubMed ID: 18653413
[No Abstract] [Full Text] [Related]
16. A new ballgame: comprehensive medication review.
McSpadden C
Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
[TBL] [Abstract][Full Text] [Related]
17. Pathway to pharmacist medical provider status in Washington State.
Hazlet TK; Karwaki TE; Downing DF
J Am Pharm Assoc (2003); 2017; 57(1):116-119. PubMed ID: 27836482
[TBL] [Abstract][Full Text] [Related]
18. Going out on your own: how to determine the value of your clinical services.
Martin CM
Consult Pharm; 2009 Nov; 24(11):817-22. PubMed ID: 20092219
[TBL] [Abstract][Full Text] [Related]
19. California bill would accord pharmacists provider status.
Thompson CA
Am J Health Syst Pharm; 2013 May; 70(10):839-40. PubMed ID: 23640341
[No Abstract] [Full Text] [Related]
20. Aid-in-dying practice in Europe and the United States: Legal and ethical perspectives for pharmacy.
Varadarajan R; Freeman RA; Parmar JR
Res Social Adm Pharm; 2016; 12(6):1016-1025. PubMed ID: 26711140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
